Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of July 13, 2026, CUE trades at $32.15 with a market cap of $154.49M and a P/E ratio of -30.63. CUE moved -14.22% today. Year to date, CUE is +305.42%; over the trailing twelve months it is +54.02%. Its 52-week range spans $4.97 to $52.50. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $32.15 |
| Market Cap | $154.49M |
| P/E Ratio | -30.63 |
| EPS | $-1.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.50 |
| 52-Week Low | $4.97 |
| Volume | 110.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.73M |
| Net Income | $-19.52M |
| Gross Margin | 0.00% |
CUE analyst coverage data. Average price target: $0.00.